Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Beta-blocker therapy after myocardial infarction with preserved ejection fraction
2017-002485-40Phase 4Active
- Sponsor
- Centro Nacional de Investigaciones Cardiovasculares
- Start
- Nov 2017
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of metoprolol, atenolol, bisoprolol and carvedilol in myocardial infarction (MI), sponsored by Centro Nacional de Investigaciones Cardiovasculares. Primary endpoint: Composite of all-cause death, reinfarction, or heart failure re-hospitalization. Started Nov 2017; status: active.
02
Drugs
metoprololatenololbisoprololcarvedilol
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on 2017-002485-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-002485-40.